Global Tumor Ablation Market is growing at a CAGR of 9.8% from 2017 to 2024

1
Global Tumor Ablation Market
Global Tumor Ablation Market is growing at a CAGR
of 9.8 from 2017 to 2024
Global Tumor Ablation Market is expected to reach
USD 3,495.0 million by 2024 from USD
1,669.7 million in 2016, at a CAGR of 9.8 in the
forecast period 2017 to 2024.  The new market
report contains data for historic years 2015, the
base year of calculation is 2016 and the forecast
period is 2017 to 2024.
Browse Full Report and Details
TOC https//databridgemarketresearch.com/reports/
global-tumour-ablation-market/
2
Report Description
The global tumor ablation market is highly
concentrated to a few big players and rest to
local players who cater to domestic markets only.
Medtronic dominated the tumor ablation market
accounting for a highest market share in 2016,
followed by Boston Scientific Corporation and
Abbott. Other players in this market include
Galil Medical Inc., Perseon Corporation, NeuWave
Medical, Inc., Koninklijke Philips N.V., INTIO
Inc., Mermaid Medical A/S, SonaCare Medical, LLC,
DFINE, Inc., Misonix, BVM Medical Limited,
AngioDynamics, COMSOL Inc, EDAP TMS, and
HealthTronics, Inc. among others holds 30.3 of
the global tumor ablation market in 2016.
Request For Free Sample Report
https//databridgemarketresearch.com/request-a-sa
mple/?dbmrglobal-tumour-ablation-market
3
Key Drivers

• Some of the major factors driving the market for
  global tumor ablation market are increasing
  incidences of cancer patients, increase in the
  number of hospitals, ablation and surgical
  centers, technological advancement in ablation
  devices. These factors increase the demand for
  devices such as tumor ablation systems and image
  guidance products.
• High treatment cost and side effects associated
  with ablation treatment may hinder the growth of
  this market.
• According to American Cancer Society, in 2017,
  approximately 1,688,780 new cancer cases were
  diagnosed and 600,920 cancer deaths were reported
  in the US.
• Many companies are increasingly focusing on
  technological advancement of devices in order to
  strengthen their product portfolios in the tumor
  ablation market.

Speak to Expert https//databridgemarketresearch
.com/speak-to-analyst/?dbmrglobal-tumour-ablation
-market
4
Market Segmentation

• The global tumor ablation market is segmented on
  the basis of type, cancer type, mode of
  treatment, end user, and geography. On the basis
  of type, the market is segmented into three major
  segments which include tumor ablation systems,
  image guidance products, and accessories. In
  2017, the Tumor Ablation Systems market segment
  is expected to dominate the market with 69.2.
  Tumor Ablation Systems is further sub segmented
  into radio frequency ablation system (RFA),
  microwave ablation system, cryoablation, high
  intensity focused ultrasound and laser ablation
  system. In 2017, radio frequency ablation system
  (RFA) market segment is expected to dominate the
  market with 53.8.
• On the basis of cancer type, the market is
  segmented into eight major segments which include
  liver cancer, brain cancer, lung cancer, bone
  cancer, kidney cancer, pancreatic cancer, breast
  cancer and others, The lung cancer market is
  expected to grow at the highest CAGR 10.7 in the
  forecast period of 2017 to 2024.

Request for Customization _at_ sopan.gedam_at_databridg
emarketresearch.com
5
About Data Bridge Market Research
An absolute way to forecast what future holds is
to comprehend the trend today! Data Bridge Market
Research set forth itself as an unconventional
and neoteric Market research and consulting firm
with unparalleled level of resilience and
integrated approaches. We are determined to
unearth  the best market opportunities and foster
efficient information for your business to thrive
in the market. Data Bridge endeavors to provide
appropriate solutions to the complex business
challenges and initiates an effortless
decision-making process. Read Continue
http//databridgemarketresearch.com/about-us/
Contact Us Sopan Gedam1-888-387-2818 (Toll
Free) sopan.gedam_at_databridgemarketresearch.com